about
A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosisCluster analysis of an extensive human breast cancer cell line protein expression map databaseElevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthmaProteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins.Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbationsCombinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.Proteomic approaches in drug discovery and development.Sputum Inflammatory Mediators Are Increased in Aspergillus fumigatus Culture-Positive Asthmatics.A statistician's perspective on biomarkers in drug development.Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist.Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy.Considerations for powering a clinical proteomics study: Normal variability in the human plasma proteome.A panel of biomarkers for disease severity in atopic dermatitisMultiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitisEASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients
P50
Q21135329-B6B74CC0-7F53-4205-8167-6152942A07EAQ28200792-F60A8C6D-B53B-46CE-A0BD-409E401EFC05Q28390947-C91E75C7-9E2D-48FF-AF8C-2EBDFAFD6D73Q31070242-28E39D21-9AEE-4596-9800-FC585F92608EQ33799732-0DD81A38-30D4-4043-8843-ACF8EBBA4E6EQ34425489-BA57AACD-987B-42E5-8FCD-3B14972B7010Q35835394-70A454CB-2337-4A34-BF34-2042CF26D7F3Q35917826-E78B54DF-3AA6-48D5-84DA-8E0F168F0F1BQ37606272-69ED4F84-2F9C-4619-AFB6-11191E81B6C9Q37967642-A23FAE77-B4A2-438E-BA9F-1E3CA322006EQ38730017-3C0DBFD3-FB94-4FFE-89A9-FAEABFDA91DDQ39030631-79C3A1EC-4CF5-4D2D-AB9E-65DF46460813Q40630276-15A761C5-4ECC-4024-BD28-8E865CA7E97FQ46650091-BCE04279-C400-4EE9-9F97-147A201F54D2Q52850031-69A0924F-71C5-4F7B-ABBD-B01FFFFD26A0Q86555452-E6229CE0-B089-4F97-B930-6530FE9E2423Q87667125-21DF97F2-4D67-4948-BA66-8C2005499CABQ88814022-E7723BCC-BEF2-45CE-A0DB-630E4227DBA3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Athula Herath
@ast
Athula Herath
@en
Athula Herath
@es
Athula Herath
@nl
type
label
Athula Herath
@ast
Athula Herath
@en
Athula Herath
@es
Athula Herath
@nl
prefLabel
Athula Herath
@ast
Athula Herath
@en
Athula Herath
@es
Athula Herath
@nl
P106
P31
P496
0000-0002-9465-7841